Education Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Education Medical Dialogues
    • News
        • Campus News
        • Colleges
        • Courses
        • Dentistry
        • Exams and Results
        • Milestones
        • Nursing
        • Paramedics
        • Pharmacy
        • Physiotherapy
        • Policy
        • Study Abroad/Scholarships
        • universities
    • Blog
    • state news
        • Andaman And Nicobar Islands
        • Andhra Pradesh
        • Arunachal Pradesh
        • Assam
        • Bihar
        • Chandigarh
        • Chattisgarh
        • Dadra And Nagar Haveli
        • Daman And Diu
        • Delhi
        • Goa
        • Gujarat
        • Haryana
        • Himachal Pradesh
        • Jammu & Kashmir
        • Jharkhand
        • Karnataka
        • Kerala
        • Ladakh
        • Lakshadweep
        • Madhya Pradesh
        • Maharashtra
        • Manipur
        • Meghalaya
        • Mizoram
        • Nagaland
        • Odisha
        • Puducherry
        • Punjab
        • Rajasthan
        • Sikkim
        • Tamil Nadu
        • Telangana
        • Tripura
        • Uttar Pradesh
        • Uttrakhand
        • West Bengal
    LoginRegister
    Education Medical Dialogues
    LoginRegister
    • Home
    • News
      • Campus News
      • Colleges
      • Courses
      • Dentistry
      • Exams and Results
      • Milestones
      • Nursing
      • Paramedics
      • Pharmacy
      • Physiotherapy
      • Policy
      • Study Abroad/Scholarships
      • universities
    • Blog
    • state news
      • Andaman And Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra And Nagar Haveli
      • Daman And Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
    • Home
    • Court Decision
    • Thalassemia candidate...

    Thalassemia candidate to be considered for a medical seat under Disability Quota: SC

    Written by Geeta Sharma Sharma Published On 2017-08-15T10:30:16+05:30  |  Updated On 15 Aug 2017 10:30 AM IST
    Thalassemia candidate to be considered for a medical seat under Disability Quota: SC

    The Supreme Court has issued a directive to the Chattisgarh Government to consider a Thalassemia patient for a medical seat under the Disability Quota.


    The bench of Justice AM Khanwilkar and Justice Deepak Mishra on August 11 ordered the Chattisgarh Government to constitute a Medical Board within two days, to undergo an examination of the candidate suffering from Thalassemia, a benchmark disability, under the Right of Persons with Disabilities Act, 2016, for the Disability Quota for granting of admission in any of the medical streams.


    The 2016 Disability Act allows for 5% reservation for individuals with benchmark disability. “The said statutory command, needless to say, has to be followed in letter and spirit”, the order of the bench noted. Describing the 2016 Act as a legislation of great welfare measures, the Court said it was everyone’s duty to see that the provisions were carried out swiftly.The bench also gave directions that the results of her medical examinations by the board be produced in court, before 18th August.


    The court was of the opinion that if the petitioner cleared the criterion as per the 2016 Act, her case be put up for consideration.
    “It is the duty of every institution to extend a helping hand in its command to the disabled persons”, the order of the bench emphasized.


    The petitioner, is a resident of Raipur, and holder of the 6th position in the physically handicapped category for the state of Chhattisgarh. The candidate had appeared for the NEET 2017 examination, held in May.


    The 2016 Act, which has broadened base with the word ‘disability’ includes more classes and cases of disability, today. Section 2(r) defines “person with benchmark disability” to be a person with not less than 40 % of a specified disability.


    Specified disability has not been defined in measurable terms and includes a person with disability, where specified disability has been defined in measurable terms, as certified by the certifying authority.


    Section 2(s) defines “person with disability” as a person with long term physical, mental, intellectual or sensory impairment which, in interaction with barriers, hinders his full and effective participation in society equally with others.


    Section 32 (1) of the Act calls for all Government institutions of higher education and other institutions to receive aid from the Government, to reserve not less than five per cent seats, for persons with benchmark disabilities.


    Whereas, Section 32(2) calls for an upper age relaxation of 5 years for admission in institutions of higher education, for persons with benchmark disabilities.


    Interestingly, the Chhattisgarh Government does not recognize the disorders under the category of disability, and therefore, disallowed the petitioner an admission just as it did other similarly situated disabled persons.


    The petitioner revealed in court that such differently-abled students are unable to get a disability certificate, in order to avail the benefit of reservations, provided under the Act.


    2016 Disability ActAct 2016Benchmark disabilityChattisgarh GovernmentDisability QuotaJustice AM KhanwilkarJustice Deepak MishraNEETright of persons with disabilitiesSupreme Courtthalassemia
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Geeta Sharma Sharma
    Geeta Sharma Sharma
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:01 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok